68 participants
Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-18
- Start Date:
- 2024-10-31
- Completion:
- 2027-04-30
Conditions
- Intrahepatic Cholangiocarcinoma (Icc)
Interventions
- DRUG
No Results Yet